financetom
Business
financetom
/
Business
/
US House lawmakers probe Delta Air Lines on use of AI in ticket pricing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US House lawmakers probe Delta Air Lines on use of AI in ticket pricing
Nov 5, 2025 9:19 AM

WASHINGTON (Reuters) -A group of two dozen U.S. House Democratic lawmakers asked Delta Air Lines ( DAL ) CEO Ed Bastian on Wednesday to answer questions about whether it will use generative artificial intelligence to help set ticket prices.

The lawmakers, including Jesus "Chuy" Garcia, Jerrold Nadler, Alexandria Ocasio-Cortez and Dan Goldman, in a letter seen by Reuters asked Delta to disclose if it will deploy AI to boost prices through "individualized, surveillance-based price discrimination."

Delta said Wednesday "there is no fare product Delta has ever used, is testing or plans to use that targets customers with individualized offers based on personal information or otherwise."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mitsubishi UFJ Financial Fiscal H1 Earnings Increase; Annual Outlook Raised -- Shares Up Pre-Bell
Mitsubishi UFJ Financial Fiscal H1 Earnings Increase; Annual Outlook Raised -- Shares Up Pre-Bell
Nov 14, 2025
06:16 AM EST, 11/14/2025 (MT Newswires) -- Mitsubishi UFJ Financial Group ( MUFG ) reported fiscal H1 earnings Friday of 112.77 Japanese yen ($0.73) per diluted share, up from 107.57 yen a year earlier. The company said it now expects full-year net income of 2.100 trillion yen, up from its prior outlook of 2 trillion yen. Mitsubishi UFJ shares were...
Fennec Pharmaceuticals Prices US$35 Million Share Offering at US$7.50
Fennec Pharmaceuticals Prices US$35 Million Share Offering at US$7.50
Nov 14, 2025
06:21 AM EST, 11/14/2025 (MT Newswires) -- Fennec Pharmaceuticals ( FENC ) , a specialty drug developer, late Thursday priced its underwritten public offering of 4,666,667 common shares at US$7.50 each. The company also granted underwriters a 30-day option to buy up to an additional 700,000 shares on the same terms. The company anticipates the total gross proceeds from the...
Nauticus Robotics Q3 revenue rises on SeaTrepid acquisition boost
Nauticus Robotics Q3 revenue rises on SeaTrepid acquisition boost
Nov 14, 2025
Overview * Nauticus Q3 revenue rises to $2.0 mln from $0.4 mln year-over-year * Company reports Q3 net loss of $6.6 mln, an improvement from prior quarter * Successful Nauticus ToolKITT integration on third-party vehicles enhances operational capabilities Outlook * Nauticus expects increased customer engagement at its lakeside facility * Company anticipates expanding customer base for software sales in 2026...
Picard Reports Third Quarter 2025 Financial Results
Picard Reports Third Quarter 2025 Financial Results
Nov 14, 2025
– Completes IPO, Expands Patent Portfolio, and Strengthens Board Independence – TUCSON, Ariz., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. ( PMI ) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced financial results for the three and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved